Biologics Spine Cerapedics Reinforces Commitment to Level 1 Evidence with Long-Term Results from Six-Year Pivotal IDE Cervical Study Demonstrating 98.6% Spine Fusion Rates in Patients Treated With i-FACTOR® byJosh SandbergOctober 17, 2023
Biologics Extremities Spine Cerapedics Announces Commercial Launch of i-FACTOR®+ Matrix in Canada byJosh SandbergNovember 5, 2020
Biologics Spine Cerapedics Announces Results from Clinical Trial of i-FACTOR® Peptide Enhanced Bone Graft in Lumbar Fusion Surgery byJosh SandbergMay 19, 2020
